vs

Side-by-side financial comparison of AEMETIS, INC (AMTX) and Cardlytics, Inc. (CDLX). Click either name above to swap in a different company.

Cardlytics, Inc. is the larger business by last-quarter revenue ($50.9M vs $43.3M, roughly 1.2× AEMETIS, INC). On growth, AEMETIS, INC posted the faster year-over-year revenue change (-7.9% vs -25.5%). Cardlytics, Inc. produced more free cash flow last quarter ($13.0M vs $-10.8M). Over the past eight quarters, Cardlytics, Inc.'s revenue compounded faster (-9.6% CAGR vs -22.8%).

Aemetis, Inc. is a renewable fuels and sustainable biochemicals producer operating across North America and India. Its core products include low-carbon ethanol, renewable natural gas and biodiesel, serving transportation, industrial and agricultural sectors with decarbonization solutions for commercial clients.

Cardlytics is a leading purchase intelligence and advertising platform that partners with major banks to analyze anonymized consumer transaction data. It delivers targeted, performance-driven ad campaigns for consumer brands, retailers and service providers, helping advertisers reach audiences based on real purchase behavior, with core operations across North America and the United Kingdom.

AMTX vs CDLX — Head-to-Head

Bigger by revenue
CDLX
CDLX
1.2× larger
CDLX
$50.9M
$43.3M
AMTX
Growing faster (revenue YoY)
AMTX
AMTX
+17.6% gap
AMTX
-7.9%
-25.5%
CDLX
More free cash flow
CDLX
CDLX
$23.8M more FCF
CDLX
$13.0M
$-10.8M
AMTX
Faster 2-yr revenue CAGR
CDLX
CDLX
Annualised
CDLX
-9.6%
-22.8%
AMTX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AMTX
AMTX
CDLX
CDLX
Revenue
$43.3M
$50.9M
Net Profit
Gross Margin
17.8%
Operating Margin
-5.7%
-12.0%
Net Margin
Revenue YoY
-7.9%
-25.5%
Net Profit YoY
EPS (diluted)
$-0.03
$-0.15

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMTX
AMTX
CDLX
CDLX
Q4 25
$43.3M
$50.9M
Q3 25
$59.2M
$47.0M
Q2 25
$52.2M
$58.0M
Q1 25
$42.9M
$56.4M
Q4 24
$47.0M
$68.3M
Q3 24
$81.4M
$61.1M
Q2 24
$66.6M
$64.0M
Q1 24
$72.6M
$62.2M
Net Profit
AMTX
AMTX
CDLX
CDLX
Q4 25
Q3 25
$-23.7M
$-72.7M
Q2 25
$-23.4M
$-9.3M
Q1 25
$-24.5M
$-13.3M
Q4 24
Q3 24
$-17.9M
$-145.2M
Q2 24
$-29.2M
$-4.3M
Q1 24
$-24.2M
$-24.3M
Gross Margin
AMTX
AMTX
CDLX
CDLX
Q4 25
17.8%
Q3 25
-0.1%
Q2 25
-6.4%
Q1 25
-11.8%
Q4 24
-4.3%
Q3 24
4.8%
Q2 24
-2.7%
Q1 24
-0.8%
Operating Margin
AMTX
AMTX
CDLX
CDLX
Q4 25
-5.7%
-12.0%
Q3 25
-14.4%
-146.6%
Q2 25
-20.4%
-22.0%
Q1 25
-36.3%
-24.9%
Q4 24
-28.7%
-12.2%
Q3 24
-4.8%
-243.1%
Q2 24
-20.4%
-24.7%
Q1 24
-13.0%
-36.7%
Net Margin
AMTX
AMTX
CDLX
CDLX
Q4 25
Q3 25
-40.1%
-154.7%
Q2 25
-44.8%
-16.0%
Q1 25
-57.2%
-23.5%
Q4 24
Q3 24
-22.0%
-237.6%
Q2 24
-43.8%
-6.7%
Q1 24
-33.4%
-39.0%
EPS (diluted)
AMTX
AMTX
CDLX
CDLX
Q4 25
$-0.03
$-0.15
Q3 25
$-0.37
$-1.36
Q2 25
$-0.41
$-0.18
Q1 25
$-0.47
$-0.26
Q4 24
$-0.29
$-0.36
Q3 24
$-0.38
$-2.90
Q2 24
$-0.66
$-0.09
Q1 24
$-0.58
$-0.56

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMTX
AMTX
CDLX
CDLX
Cash + ST InvestmentsLiquidity on hand
$4.9M
$48.7M
Total DebtLower is stronger
$212.6M
Stockholders' EquityBook value
$-306.8M
$-6.5M
Total Assets
$259.8M
$285.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMTX
AMTX
CDLX
CDLX
Q4 25
$4.9M
$48.7M
Q3 25
$5.6M
$44.0M
Q2 25
$1.6M
$46.7M
Q1 25
$499.0K
$52.0M
Q4 24
$898.0K
$65.6M
Q3 24
$296.0K
$67.0M
Q2 24
$234.0K
$71.2M
Q1 24
$1.6M
$97.8M
Total Debt
AMTX
AMTX
CDLX
CDLX
Q4 25
$212.6M
Q3 25
$214.6M
Q2 25
$214.3M
Q1 25
$213.9M
Q4 24
$338.1M
$213.6M
Q3 24
$322.2M
$213.2M
Q2 24
$309.0M
$212.9M
Q1 24
$307.2M
$257.9M
Stockholders' Equity
AMTX
AMTX
CDLX
CDLX
Q4 25
$-306.8M
$-6.5M
Q3 25
$-304.9M
$-4.7M
Q2 25
$-289.3M
$58.7M
Q1 25
$-280.7M
$64.1M
Q4 24
$-263.9M
$70.0M
Q3 24
$-258.9M
$69.7M
Q2 24
$-249.0M
$210.0M
Q1 24
$-232.1M
$199.1M
Total Assets
AMTX
AMTX
CDLX
CDLX
Q4 25
$259.8M
$285.6M
Q3 25
$241.1M
$292.8M
Q2 25
$240.0M
$361.1M
Q1 25
$242.5M
$369.1M
Q4 24
$259.3M
$392.7M
Q3 24
$259.3M
$399.4M
Q2 24
$259.3M
$534.4M
Q1 24
$259.3M
$569.0M
Debt / Equity
AMTX
AMTX
CDLX
CDLX
Q4 25
Q3 25
Q2 25
3.65×
Q1 25
3.34×
Q4 24
3.05×
Q3 24
3.06×
Q2 24
1.01×
Q1 24
1.29×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMTX
AMTX
CDLX
CDLX
Operating Cash FlowLast quarter
$5.8M
$13.0M
Free Cash FlowOCF − Capex
$-10.8M
$13.0M
FCF MarginFCF / Revenue
-24.9%
25.5%
Capex IntensityCapex / Revenue
38.2%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-22.7M
$8.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMTX
AMTX
CDLX
CDLX
Q4 25
$5.8M
$13.0M
Q3 25
$3.1M
$1.8M
Q2 25
$-5.7M
$1.2M
Q1 25
$160.0K
$-6.7M
Q4 24
$-12.6M
$3.0M
Q3 24
$-5.0M
$1.4M
Q2 24
$-5.1M
$4.4M
Q1 24
$-10.3M
$-17.6M
Free Cash Flow
AMTX
AMTX
CDLX
CDLX
Q4 25
$-10.8M
$13.0M
Q3 25
$-1.0M
$1.7M
Q2 25
$-9.3M
$903.0K
Q1 25
$-1.7M
$-6.8M
Q4 24
$-19.4M
$2.9M
Q3 24
$-9.5M
$878.0K
Q2 24
$-10.5M
$4.1M
Q1 24
$-13.9M
$-18.3M
FCF Margin
AMTX
AMTX
CDLX
CDLX
Q4 25
-24.9%
25.5%
Q3 25
-1.7%
3.7%
Q2 25
-17.7%
1.6%
Q1 25
-3.9%
-12.1%
Q4 24
-41.2%
4.2%
Q3 24
-11.6%
1.4%
Q2 24
-15.8%
6.5%
Q1 24
-19.1%
-29.4%
Capex Intensity
AMTX
AMTX
CDLX
CDLX
Q4 25
38.2%
0.0%
Q3 25
6.9%
0.0%
Q2 25
6.7%
0.6%
Q1 25
4.3%
0.2%
Q4 24
14.4%
0.2%
Q3 24
5.5%
0.8%
Q2 24
8.1%
0.4%
Q1 24
4.9%
1.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMTX
AMTX

Ethanol Sales$28.8M66%
Wet Distillers Grains$6.8M16%
California Dairy Renewable Natural Gas$5.2M12%
Other$1.8M4%

CDLX
CDLX

Segment breakdown not available.

Related Comparisons